Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapies for the ...
Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) ("Profound" or the "Company"), a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapies for the ...
Francis Medical, Inc., a privately held medical device company, announced today the successful completion of the first commercial (non-clinical study) procedure on the East Coast using the Vanquish(R) ...
Men with prostate cancer have a major decision to make: whether to get a lifesaving surgery. Radical prostatectomy, the ...
World’s first robotic Prostatic Artery Embolization (PAE) for Benign Prostatic Hyperplasia (BPH) and robotic Y-90 ...
Wrapping dehydrated human amniotic membrane around nerve and anastomotic tissue during robotic prostatectomy was associated ...
Francis Medical, Inc., a privately held medical device company, announced today the successful completion of the first commercial (non-clinical study) procedure on the East Coast using the Vanquish® ...
If urinary symptoms are affecting you, consult a urologist to explore advanced, minimally invasive treatments like Prostatic Urethral Lift (UroLift). Today's BPH treatments are designed to relieve ...
Elidah today announced FDA clearance of Elitone for Men, a non-invasive, at-home treatment designed to help men regain ...
Detailed price information for Profound Medical Corp (PROF-Q) from The Globe and Mail including charting and trades.
– First multicenter, randomized controlled trial directly comparing a new technology to robotic RP for men with localized prostate cancer to successfully recruit to target enrollment – – TULSA ...